On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV-1 IFA test kits. The original communication indicated that CTS inventory would be exhausted by September 1, 2019 but we now have sufficient inventory to last until September 30, 2019.
Check out the Communication page for the complete details by clicking the link: Communications
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...